254 related articles for article (PubMed ID: 21277864)
1. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.
Reis GM; Ramos MA; Pacheco Dda F; Klein A; Perez AC; Duarte ID
Life Sci; 2011 Apr; 88(15-16):653-7. PubMed ID: 21277864
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
3. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
4. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
5. α
Romero TRL; Miranda E Castor MG; Parrella C; Piscitelli F; Di Marzo V; Duarte IDG
Pharmacol Rep; 2020 Feb; 72(1):96-103. PubMed ID: 32016857
[TBL] [Abstract][Full Text] [Related]
6. N-palmitoyl-ethanolamine (PEA) induces peripheral antinociceptive effect by ATP-sensitive K+-channel activation.
Romero TR; Duarte ID
J Pharmacol Sci; 2012; 118(2):156-60. PubMed ID: 22343363
[TBL] [Abstract][Full Text] [Related]
7. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level.
Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G
Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592
[TBL] [Abstract][Full Text] [Related]
8. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by ketamine.
Romero TR; Duarte ID
Vet Anaesth Analg; 2013 Jul; 40(4):419-24. PubMed ID: 23490455
[TBL] [Abstract][Full Text] [Related]
9. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
Amarante LH; Alves DP; Duarte ID
Eur J Pharmacol; 2004 Jun; 494(2-3):155-60. PubMed ID: 15212969
[TBL] [Abstract][Full Text] [Related]
10. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
11. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by the alpha(2)-adrenoceptor agonist xylazine.
Romero TR; Duarte ID
J Pharmacol Sci; 2009 Dec; 111(4):323-7. PubMed ID: 20019444
[TBL] [Abstract][Full Text] [Related]
13. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation.
Alves DP; Tatsuo MA; Leite R; Duarte ID
Life Sci; 2004 Apr; 74(20):2577-91. PubMed ID: 15010267
[TBL] [Abstract][Full Text] [Related]
14. Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels.
Reis GM; Duarte ID
Br J Pharmacol; 2006 Nov; 149(6):733-9. PubMed ID: 17016510
[TBL] [Abstract][Full Text] [Related]
15. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID
Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156
[TBL] [Abstract][Full Text] [Related]
16. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
17. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.
Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL
J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851
[TBL] [Abstract][Full Text] [Related]
18. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
19. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
